Safetyome and Specialized Panels for Over 3,000 Phenotypes: a Systematic and Translational Approach using Human Genetics and Pharmacology
Toxicological Sciences · 2026
DOI: 10.1093/toxsci/kfag021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2026. Verfasst von Xin Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Sciences & Translational Safety, Johnson & Johnson, 3210 Merryfield Rd, San Diego, CA 92121, USA. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Translational Research, Biomedical. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson.
Abstract (Originalsprache)
Drug candidates are often evaluated for their activities against unexpected targets (off-targets), to either prospectively flag potential hazards or to provide mechanistic insights for a given phenotype. The in vitro to in vivo translatability is critical when selecting which “phenotypically consequential” off-targets to screen. To this end, human genetics and indication-based pharmacology offer unraveled insights. Enhanced natural language processing tools were applied to harness the power of large data obtained from 7 genetics and 2 pharmacology databases. Mapping biological roles to organ systems, we curated targets implicated in 22 organ systems of safety concerns, resulting in a safetyome composed of over ∼11,000 proteins. This is a significant expansion from our previously proposed screen, whose scope included phenotypes affecting 5 organ systems. Prioritization of the large panel using expression pattern and gene conservation across species resulted in a core panel of 500 targets. Mapping biological roles obtained from the databases to specific terms allowed us to systematically generate over 3,000 phenotype-based (specialized) panels, which can be used as gene or protein sets for issue resolution. All three components: The full safetyome, the core panel of 500 targets, and the over 3,000+ specialized panels, were systematically and orthogonally tested using independent data source, i.e., gene expression data from the Comparative Toxicogenomics Database. All panels, together with a user-friendly App, are published to aid effective safety assessment and issue resolution with strong “translational” focus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Preclinical Sciences & Translational Safety, Johnson & Johnson, 3210 Merryfield Rd, San Diego, CA 92121, USA.
- In silico Discovery, Johnson & Johnson, 1400 McKean Rd, Spring House, PA 19477, USA.
Förderung
- Johnson & Johnson
Zitieren
APA
Liu, X., Chen, Y. W., Xu, X., Smith, D., & Fan, F. (2026). Safetyome and Specialized Panels for Over 3,000 Phenotypes: a Systematic and Translational Approach using Human Genetics and Pharmacology. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfag021
Vancouver
Liu X, Chen YW, Xu X, Smith D, Fan F. Safetyome and Specialized Panels for Over 3,000 Phenotypes: a Systematic and Translational Approach using Human Genetics and Pharmacology. Toxicological Sciences. 2026. doi:10.1093/toxsci/kfag021
BibTeX
@article{Liu2026,
author = {Liu, Xin and Chen, Yen-Wei and Xu, Xiao and Smith, David and Fan, Fan},
title = {Safetyome and Specialized Panels for Over 3,000 Phenotypes: a Systematic and Translational Approach using Human Genetics and Pharmacology},
journal = {Toxicological Sciences},
year = {2026},
doi = {10.1093/toxsci/kfag021}
}
EUVIMED